...
首页> 外文期刊>Journal of human hypertension >Comparison between isosorbide dinitrate aerosol and nifedipine in the treatment of hypertensive emergencies.
【24h】

Comparison between isosorbide dinitrate aerosol and nifedipine in the treatment of hypertensive emergencies.

机译:硝酸异山梨酯气雾剂与硝苯地平治疗高血压急症的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Nitric oxide donors have been used in the management of hypertensive emergencies (HE). Isosorbide dinitrate aerosol (ISA) is a nitric oxide fast-acting donor. The aim of this study is to compare the efficacy of ISA and nifedipine in the treatment of HE. METHODS: Sixty adult patients with an HE were randomised to receive either ISA (2.5 mg) or nifedipine (10 mg). Patients were given an electrocardiogram (ECG) immediately prior, and 30 min after administering the medication. Blood pressure (BP) was measured every 5 min for the first 30 min, and then every 30 min for a period of 6 h. RESULTS: Blood pressure values for all patients in the ISA group decreased significantly (187 +/- 13/121 +/- 6 to 153 +/- 15/92.3 +/- 7.6 mmHg, P < 0.005). Two of the patients in this group had angor pectoris with evidence of subepicardial ischaemia as seen in the first ECG, both of which disappeared with the drug. Heart rate decreased by 14%. Similarly, all patients in the nifedipine group had significant decreases in BP (190 +/- 23/115 +/- 7 to 153 +/- 26/86 +/- 6 mm Hg, P < 0.005). Their first ECG was normal. Two patients suffered angor pectoris after nifedipine, with subepicardial ischaemia registering in the second ECG. Heart rate increased 11.9% in this group. During the follow-up period, no clinically significant side effects or cases of rebound hypertension were observed in the ISA group, whereas in the nifedipine group, eight patients reported having headaches and four others rebound hypertension. CONCLUSION: Our results show a favourable effect of ISA in the treatment of HE.
机译:背景:一氧化氮供体已用于高血压紧急情况(HE)的管理中。硝酸异山梨酯气雾剂(ISA)是一氧化氮速效供体。这项研究的目的是比较ISA和硝苯地平治疗HE的疗效。方法:将60名成人HE患者随机分为ISA(2.5毫克)或硝苯地平(10毫克)。在服药前和服药后30分钟为患者提供心电图(ECG)。在最初的30分钟内每5分钟测量一次血压(BP),然后在6小时内每30分钟测量一次。结果:ISA组所有患者的血压值均显着降低(187 +/- 13/121 +/- 6至153 +/- 15 / 92.3 +/- 7.6 mmHg,P <0.005)。在该组中,有两名患者患有胸大肌,并在第一次ECG中见到了心外膜下缺血的迹象,但均随药物消失。心率下降14%。同样,硝苯地平组的所有患者血压均显着降低(190 +/- 23/115 +/- 7至153 +/- 26/86 +/- 6 mm Hg,P <0.005)。他们的第一个心电图正常。两名患者在硝苯地平治疗后出现了血管性胸大肌,第二个心电图记录了心外膜下缺血。该组的心率增加11.9%。在随访期间,ISA组未观察到临床上显着的副作用或反弹性高血压病例,而硝苯地平组中,八名患者报告有头痛,另外四名发生反弹性高血压。结论:我们的结果显示了ISA治疗HE的良好效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号